Abnormalities of Potassium in Heart Failure
João Pedro Ferreira(Inserm), Faı̈ez Zannad(Centre d’Investigation Clinique Innovation Technologique de Nancy), Patrick Rossignol(Inserm), Javed Butler(Jackson Memorial Hospital), Matthew R. Weir(University of Maryland, Baltimore), Mikhail Kosiborod(AstraZeneca (Brazil)), Lars H. Lund(Karolinska University Hospital), Bertram Pitt(University of Michigan), Stefan D. Anker(Charité - Universitätsmedizin Berlin), George L. Bakris(Pennsylvania State System of Higher Education)
Cited by 177
Related Papers
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|Hypertension|2003|13.3k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
|New England Journal of Medicine|1999|9.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k